Sun & Lake Pharmacy, Inc.; D/B/A the Medicine Shoppe; Revocation of Registration

Justice Department; Drug Enforcement Administration · 2011

Read Sun & Lake Pharmacy, Inc.; D/B/A the Medicine Shoppe; Revocation of Registration by Justice Department; Drug Enforcement Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-10506.txt.

Description

Notice published in the Federal Register on 2011-05-02 by Justice Department; Drug Enforcement Administration. Text from federalregister.gov (official edition: govinfo). [Pages 24523-24533] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-10506] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. 10-18] Sun & Lake Pharmacy, Inc.; D/B/A the Medicine Shoppe; Revocation of Registration On October 19, 2009, the Deputy Assistant Administrator, Office of Diversion Control, Drug.

Catalog record

CREATORJustice Department; Drug Enforcement Administration
YEAR2011
COLLECTIONLAW
FORMATTXT
FILE SIZE78 KB
VERSION1.0
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEFederal Register

Source: https://www.federalregister.gov/documents/2011/05/02/2011-10506/sun-and-lake-pharmacy-inc-dba-the-medicine-shoppe-revocation-of-registration

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Sun & Lake Pharmacy, Inc.; D/B/A the Medicine Shoppe; Revocation of Registration Citation: us:fr:2011-10506 Creator: Justice Department; Drug Enforcement Administration Year: 2011 Source-URL: https://www.federalregister.gov/documents/2011/05/02/2011-10506/sun-and-lake-pharmacy-inc-dba-the-medicine-shoppe-revocation-of-registration Context: Notice published in the Federal Register on 2011-05-02 by Justice Department; Drug Enforcement Administration. Text from federalregister.gov (official edition: govinfo). [Pages 24523-24533] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-10506] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. 10-18] Sun & Lake Pharmacy, Inc.; D/B/A the Medicine Shoppe; Revocation of Registration On October 19, 2009, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, issued an Order to Show Cause to Sun & Lake Pharmacy, Inc., d/b/a The Medicine Shoppe (hereinafter, Respondent) of Lakeland, [[Page 24524]] Florida. The Show Cause Order proposed the revocation of Respondent's Certificate of Registration, BS9433828, as a retail pharmacy, and the denial of any pending applications to renew or modify the registration, on the ground that its registration is ``inconsistent with the public interest.'' ALJ Ex. 1, at 1 (citing 21 U.S.C. 823(f) & 824(a)(4)). More specifically, the Show Cause Order alleged that Respondent had violated both federal and state laws by distributing controlled substances to persons throughout the United States ``based on purported prescriptions issued to hundreds of customers through Internet websites * * * by physicians who were not licensed to practice medicine in the states in which the customers resided.'' Id. at 2 (citations omitted). The Show Cause Order also alleged that the prescriptions violated 21 CFR 1306.04(a) because the ``physicians failed to establish a valid physician-patient relationship as required by multiple state laws'' and were therefore issued ``for other than a legitimate medical purpose and/or outside the usual course of professional practice.'' Id. at 3 (citations omitted). Finally, the Order alleged that Respondent filled unlawful prescriptions issued by one Robert Reppy, D.O., because Reppy ``issued * * * prescriptions for controlled substances to customers throughout the United States even though he was licensed to practice medicine only in the State of Florida'' and was therefore engaged in the unauthorized practice of medicine when he prescribed to persons outside of Florida. Id. The Order also alleged that Reppy violated Florida law by ``issuing prescriptions via the Internet without a documented patient evaluation and discussion between [him] and [the] patient regarding treatment options.'' Id. (citations omitted). On November 23, 2009, Respondent, through its counsel, requested a hearing on the allegations and the matter was placed on the docket of the DEA Administrative Law Judges (ALJs). ALJ Ex. 2. Following pre- hearing procedures, on February 24-25, 2010, an ALJ conducted a hearing in Tampa, Florida. At the hearing, the Government called witnesses to testify and introduced extensive documentary evidence; Respondent called no witnesses and introduced a single exhibit. Following the hearing, both parties submitted briefs containing their proposed findings of fact, conclusions of law and argument. On April 8, 2010, the ALJ issued his Recommended Decision (also ALJ). As to factor one--the recommendation of the state licensing authority--the ALJ noted that there was no evidence that the State licensing authority had taken any action against Respondent's pharmacy license. ALJ at 28. The ALJ noted, however, that while state licensure is a necessary condition for holding a registration, Respondent's continued holding of its state license is not dispositive because DEA has an ``independent responsibility to determine whether a registration is in the public interest.'' Id. (citations omitted). The ALJ thus concluded that Respondent's licensure status neither ``weigh[s] for or against a determination'' that its ``continued registration * * * is consistent with the public interest.'' Id. As to factor three--Respondent's record of conviction of offenses related to the distribution or dispensing of controlled substances--the ALJ noted that while Respondent remains the subject of a criminal investigation, it has not been ``convicted of any crime.'' Id. The ALJ reasoned, however, that ``the probative value'' of this finding ``is somewhat diminished by the myriad of considerations that are factored into a decision to initiate, pursue, and dispose of criminal proceedings by'' the prosecuting authorities. Id. at 28. The ALJ apparently concluded that this factor neither supported nor refuted the conclusion that Respondent's continued registration is inconsistent with the public interest. Id. at 29. The ALJ considered the remaining factors--its experience in dispensing controlled substances (factor two), its compliance with applicable laws relating to controlled substances (factor four), and other conduct which may threaten public health and safety (factor five)--together. Id. at 29-48. With regard to these factors, the ALJ noted that there were two primary issues: (1) Whether Respondent complied with its ``corresponding responsibility'' under 21 CFR 1306.04(a) to not knowingly fill a prescription which has not been issued for a legitimate medical purpose, and (2) whether it ``was authorized to dispense controlled substances to the ultimate user who received them where they were delivered.'' Id. at 32. As to the first issue, the ALJ explained that a ``pharmacy registrant must understand the requirements attendant upon the issuance of an effective prescription under the regulations.'' Id. at 33. The ALJ further noted that under the Controlled Substances Act, ``it is fundamental that a physician practitioner must have established a bona fide doctor-patient relationship in order to act `in the usual course of professional practice' and to issue a prescription `for a legitimate medical purpose,' '' and that at the time of the conduct at issue, ``the CSA generally looked to state law to determine whether a bona fide doctor patient relationship existed.'' Id. at 33-34 (citations omitted). The ALJ also explained that under agency precedent, `` `an entity which voluntarily engages in commerce by shipping controlled substances to persons located in other States is properly charged with knowledge of the laws regarding both the practice of medicine and pharmacy in those States,' '' and this obligation includes `` `determin[ing] whether the physicians were in compliance with the States' licensure requirements and specific standards for issuing treatment recommendations and prescribing controlled substances.' '' Id. at 38 (quoting Bob's Pharmacy & Diabetic Supplies, 74 FR 19599, 19601 (2009); United Prescriptions Servs., Inc., 72 FR 50397, 50408 (2007)). Moreover, the ALJ also cited Agency precedent that, under the CSA, ``a physician who engages in the unauthorized practice of medicine under state law is not `a practitioner acting in the usual course of * * * professional practice,' '' and that ``a controlled-substance prescription issued by a physician who lacks the license or other authority required to practice medicine within a State is therefore unlawful under the CSA.'' Id. (citations omitted). The ALJ also concluded that Respondent had ignored evidence that the prescriptions were not issued pursuant to a valid doctor-patient relationship. The ALJ noted that a DEA Diversion Investigator (DI) had provided Respondent with various documents including a Guidance Document on Dispensing and Purchasing Controlled Substances Over the Internet, 66 FR 21181 (2001), which explained four widely accepted elements for establishing a bona fide doctor-patient relationship (including, inter alia, that a medical history be taken and a physical examination be performed) and the DEA Pharmacist's Manual. ALJ at 34- 35. The ALJ also found that Respondent's owner had expressed to the DI that it had been solicited to distribute drugs for an internet prescribing scheme

Read the complete text